Tradestie Institutional Equity Comparison Engine
SRTM vs BDRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDRX Overall Edge
BDRX Captures Institutional Edge (2โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SRTM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BDRX at N/M Forward P/E and 0.0% operating margin (-64.1% YoY). In options structure, SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SRTM N/M vs BDRX N/M Fwd P/E
Growth & Margin Winner
BDRX
Op Margin N/A vs 0.0% ยท YoY N/A vs -64.1%
Momentum & Technical Winner
BDRX
1Y -86.8% vs -51.4% ยท 52W Pos 2% vs 18%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SRTM
US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap
N/A
1M Return
-80.4%
1Y Return
-86.83%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
BDRX
NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap
$1.0M
1M Return
+352.9%
1Y Return
-51.42%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SRTM -86.83%
BDRX -51.42%
Spread: +466.86 pp (BDRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SRTM TTM Op. Margin: N/A
BDRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs BDRX. Trailing 12-month operating profitability (SRTM N/A vs BDRX 0.0%) and valuation multiples (SRTM N/M vs BDRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SRTM | BDRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.0M | Larger Scale | BDRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -64.1% | Higher Growth | BDRX |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | BDRX |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | BDRX |
| Return on Equity (ROE) Capital Efficiency | N/A | -42.0% | Higher ROE | BDRX |
| 52-Week Range Position Momentum | 2% ($0โ$1) | 18% ($0โ$9) | Stronger Trend | BDRX |
| Beta / 30D Volatility Risk Regime | N/A | 5.62ฮฒ ยท 2621% Vol | Lower Realized Risk | SRTM |
| Unified Institutional Score Composite Signal | 47.6 / 100 (HOLD) | 36.0 / 100 (SELL) | Higher Composite | SRTM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SRTM vs BDRX Buy Guide
SRTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BDRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SRTM nor BDRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.